Medicine for adjunctively treating prostatic disease
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An adjuvant therapy, prostate technology, applied in drug combinations, urinary system diseases, pharmaceutical formulations, etc., can solve the problems of ineffective control of diseases, poor efficacy, etc., to prevent and improve prostate diseases, improve resistance, and prevent prostate cancer. Effect
Inactive Publication Date: 2011-09-14
WUHAN JINJUYE BIOTECH
View PDF1 Cites 10 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0014] Due to the extremely complicated pathology of prostate disease, if these herbal medicines are used alone, not only the curati...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] The medicine for auxiliary treatment of prostate disease of the present invention is made of the following raw materials in parts by weight: 160 mg of Saw palmetto extract, 25 mg of Pygeum africana extract, 20 mg of pumpkin seed extract, 10 mg of lycopene and 3 mg of zinc.
[0030] Preparation method: the main ingredients are mixed in proportion with saw palmetto extract, pygeum africana extract, pumpkin seed extract, lycopene and zinc, and soybean oil, soybean lecithin, glycerin and gelatin are used as auxiliary materials. Sol, press pellets, and dry to make soft capsule preparations.
[0031] Usage and dosage: twice a day, take one soft capsule each time, orally.
Embodiment 2
[0033] The medicine for auxiliary treatment of prostate disease of the present invention is made of the following raw materials in parts by weight: 180 mg of Saw palmetto extract, 30 mg of Pygeum africana extract, 30 mg of pumpkin seed extract, 15 mg of lycopene and 5 mg of zinc.
[0034] The preparation method is the same as in Example 1.
[0035] Usage and dosage: twice a day, take one soft capsule each time, orally.
Embodiment 3
[0037] The medicine for auxiliary treatment of prostate disease of the present invention is made of the following raw materials in parts by weight: 160 mg of Saw palmetto extract, 25 mg of Pygeum africana extract, 20 mg of pumpkin seed extract, 3 mg of lycopene and 2 mg of zinc.
[0038] The preparation method is the same as in Example 1.
[0039] Usage and dosage: twice a day, take one soft capsule each time, orally.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a medicine for adjunctively treating prostatic diseases, which is a medicament prepared from the following raw materials and pharmaceutically acceptable auxiliary materials in parts by weight: 160-260 parts of sabal extracts, 25-72 parts of pygeum topengii extracts, 20-80 parts of pumpkinseed extracts, 3-20 parts of lycopene and 2-15 parts of zinc. The medicine is used for treating the prostatic diseases by taking the sabal extracts and the pygeum topengii extracts as main raw materials; the synergistic effect is enhanced through the pumpkinseed extracts to play an important role in enhancing the bioavailability of the effectively components of the sabal extracts; the antioxidant ability of organisms and the resistance can be enhanced through the lycopene; and the risks of prostatic cancers is reduced by preventing and improving the prostatic diseases through the lycopene and the zinc; the medicine provided by the invention accords with the traditional Chinese medicine theory and has more scientific formula and more outstanding effect; through clinical verification, the medicine has better curative effect on the prostatic diseases; in addition, the medicine provided by the invention can be taken for a long time without toxic side effect and has the effects of disease prevention and treatment.
Description
technical field [0001] The invention relates to a medicine, in particular to a medicine for auxiliary treatment of prostate diseases. Background technique [0002] Prostate disease is a disease with high incidence and difficult treatment. It generally includes acute and chronic prostatitis, bacterial prostatitis, benign prostatic hyperplasia, prostate cancer, etc. It is a common disease that plagues men. Common symptoms of prostate disease are frequent urination, urgency, painful urination, dripping white, low back pain, and even sexual dysfunction. The clinical symptoms of prostate disease are complex and often prone to recurrence. [0003] At present, the main treatment methods for prostatitis are drugs and surgery. However, due to the special physiological structure of the prostate, it is difficult for ordinary drugs to enter the interior of the prostate through a layer of hard fatty membrane wrapped around the outside of the prostate; moreover, due to the special path...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more